A Review of New Coronavirus Vaccines and Virus Detection Methods

Lin Liu; Yun Liu

doi:10.54097/ijbls.v2i3.8653

Authors

Lin Liu
Yun Liu

DOI:

https://doi.org/10.54097/ijbls.v2i3.8653

Keywords:

New Coronavirus, Vaccine, Detection, Research Progress

Abstract

As the new crown virus epidemic becomes more and more intense around the world, more and more people are pinning their hopes of containing the epidemic on the development of new crown virus vaccines. At present, the new crown vaccines developed by countries around the world are gradually being marketed. This article summarizes the development of five major new coronavirus vaccines: inactivated vaccines, live attenuated vaccines, adenovirus vector vaccines, recombinant protein vaccines, and nucleic acid vaccines. It also illustrates relevant assays for the new coronavirus.

Downloads

Download data is not yet available.

References

Kangzhuang; Tang Mei, Research progress and analysis of novel coronavirus vaccine.Journal of Biomedical Engineering 2020, 37 (03), 373-379.

Liao Pan; Xiao Yijun, Overview of research and development strategy and progress of COVID-19 vaccine Biology Teaching 2021, 46 (05), 8-10.

Guan, G. W.; Gao, L.; Wang, J. W.; Wen, X. J.; Mao, T. H.; Peng, S. W.; Zhang, T.; Chen, X. M.; Lu, F. M., Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia. Chinese journal of hepatology 2020, 28 (2), 100-106.

Zhu Yao; We iina; Sun Chang; He Hanqing, Research progress of novel coronavirus pneumonia vaccine .Preventive Medicine 2021, 33 (02), 143-148.

Zhu, F.-C.; Guan, X.-H.; Li, Y.-H.; Huang, J.-Y.; Jiang, T.; Hou, L.-H.; Li, J.-X.; Yang, B.-F.; Wang, L.; Wang, W.-J.; Wu, S.-P.; Wang, Z.; Wu, X.-H.; Xu, J.-J.; Zhang, Z.; Jia, S.-Y.; Wang, B.-S.; Hu, Y.; Liu, J.-J.; Zhang, J.; Qian, X.-A.; Li, Q.; Pan, H.-X.; Jiang, H.-D.; Deng, P.; Gou, J.-B.; Wang, X.-W.; Wang, X.-H.; Chen, W., Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet 2020, 396 (10249), 479-488.

COVID-19 vaccine: scientific war, competition between big countries. Journalist Observation 2021, (7), 89-91.

Phase I/II clinical study of COVID-19 vaccine was uncovered. Chinese Community Physicians 2020, 36 (17), 127.

Keech, C.; Albert, G.; Cho, I.; Robertson, A.; Reed, P.; Neal, S.; Plested, J. S.; Zhu, M.; Cloney-Clark, S.; Zhou, H.; Smith, G.; Patel, N.; Frieman, M. B.; Haupt, R. E.; Logue, J.; McGrath, M.; Weston, S.; Piedra, P. A.; Desai, C.; Callahan, K.; Lewis, M.; Price-Abbott, P.; Formica, N.; Shinde, V.; Fries, L.; Lickliter, J. D.; Griffin, P.; Wilkinson, B.; Glenn, G. M., Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine. New England Journal of Medicine 2020, 383 (24), 2320-2332.

Wang Yuemin, Lei Ximei, Wu Li, et al Research progress on novel coronavirus and its detection methods .Journal of China University of Metrology, 2020,31 (1): 1-7.

Ottesen, E. A.; Hong, J. W.; Quake, S. R.; Leadbetter, J. R., Microfluidic digital PCR enables multigene analysis of individual environmental bacteria. Science (New York, N.Y.) 2006, 314 (5804), 1464-1467.

Chauhan, G.; Madou, M. J.; Kalra, S.; Chopra, V.; Ghosh, D.; Martinez-Chapa, S. O., Nanotechnology for COVID-19: Therapeutics and Vaccine Research. ACS Nano 2020, 14 (7), 7760-7782.